Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial

Author(s):
Heijde, D. van der; Braun, J.; Dougados, M.; Sieper, J.; Pedersen, R.; Szumski, A.; Koenig, A.S.
Published
2012
Publication type
Article / Letter to editor
ankylosing spondylitisASDASASASBASDAIetanerceptTNF-alpha inhibitorsulphasalazineC-reactive protein
Date issued
2012-10-31
Language
English
Is part of
Rheumatology (2012), Vol. 51, no. 10, p. 1894-1905
hdl
1887/110551
doi
10.1093/rheumatology/kes142